A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
Marco Tagliamento, Paolo Bironzo, H. Curcio, Emmanuele De Luca, Daniele Pignataro, S.G. Rapetti, Marco Audisio, Valentina Bertaglia, C. Paratore, Maristella Bungaro, Emanuela Olmetto, Elisa Artusio, Maria Lucia Reale, Clizia Zichi, Enrica Capelletto, Simona Carnio, L Buffoni, Francesco Passiglia, Silvia Novello, Giorgio V. Scagliotti, Massimo Di Maïo
Topics & Concepts
MedicineOncologyInternal medicineMesotheliomaConfidence intervalStage (stratigraphy)PD-L1Clinical trialHazard ratioDiseaseImmune checkpointMeta-analysisImmunotherapyPathologyCancerBiologyPaleontologyOccupational and environmental lung diseasesCancer Immunotherapy and BiomarkersMultiple and Secondary Primary Cancers